Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis

Increasing serum-COMP levels between diagnosis and the subsequent 3 months in patients with early RA represents a novel indicator of an activated destructive process in the joint and is a promising tool to identify patients with significant joint damage progression during a 5-year period.